We serve Chemical Name:GSK-4716 CAS:101574-65-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:GSK-4716
CAS.NO:101574-65-6
Synonyms:GSK 4716;2gpp;QCR-163;GSK-4716
Molecular Formula:C17H18N2O2
Molecular Weight:282.33700
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.12g/cm3
Index of Refraction:1.576
PSA:61.69000
Exact Mass:282.13700
LogP:3.67040
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3077 9 / PGIII
Packing Group:
Contact us for information like GSK 4716 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,GSK-4716 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,QCR-163 Use and application,GSK 4716 technical grade,usp/ep/jp grade.
Related News: The announcement comes on top of Recipharm’s move into Morocco, which was fueled by local pledges of $500 million. The new facility under construction and due for completion in 2023 will employ 300 and have a capacity of 300 million units annually. 1-methyl-2,4-diphenyl-1,2,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-3-one manufacturers Our COVID-19 vaccine, Vaxzevria, undergoes extremely robust safety and quality testing prior to becoming available for patients. 8-hydroxy-1,2,3,4-tetrahydro-2-quinolone-4-carboxylic acid suppliers “The acquisition of Vanamali Organics represents the next stage of this investment strategy,” Wavelength CEO Iftach Seri said in a statement. ” We are delighted to add their talented team and advanced development and manufacturing capabilities to Wavelength, and we expect they will be important contributors to our global supply chain network and our rapidly growing custom development and manufacturing services business.” 8-Methyl-4-methylsulfanyl-1,6-dipropyl-imidazo[1,5-d][1,2,4]triazine vendor & factory Altogether, the IPO added $550 million to the family’s collective fortune, which now stands at an estimated $4.8 billion. ,Our COVID-19 vaccine, Vaxzevria, undergoes extremely robust safety and quality testing prior to becoming available for patients.
